• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在医疗保健机构中获取药物经济学数据。

Obtaining pharmacoeconomic data in health care organizations.

作者信息

Kozma C M, Kirchdoerfer L J

机构信息

College of Pharmacy, University of South Carolina, Columbia.

出版信息

Top Hosp Pharm Manage. 1994 Jan;13(4):23-30.

PMID:10130680
Abstract

The article illustrates the process and techniques of obtaining or collecting pharmacoeconomic data in various health care organizations, focusing on hospitals, physicians' offices, and pharmacies as the research settings. The role that pharmacoeconomic data have in the decision-making process as well as the perspective of the decision maker are also discussed. The three primary components needed to conduct a complete pharmacoeconomic analysis (clinical outcomes, humanistic outcomes, and economic outcomes) are described in relation to the health care organization. The strengths, weaknesses, advantages, and disadvantages of such data are discussed. Various databases that are accessible within each organization are also outlined.

摘要

本文阐述了在各类医疗保健机构中获取或收集药物经济学数据的过程与技术,重点以医院、医生诊所和药房作为研究场所。还讨论了药物经济学数据在决策过程中的作用以及决策者的视角。结合医疗保健机构描述了进行完整药物经济学分析所需的三个主要组成部分(临床结果、人文结果和经济结果)。讨论了此类数据的优点、缺点、优势和劣势。还概述了每个机构内可获取的各种数据库。

相似文献

1
Obtaining pharmacoeconomic data in health care organizations.在医疗保健机构中获取药物经济学数据。
Top Hosp Pharm Manage. 1994 Jan;13(4):23-30.
2
Pharmacoeconomics: a managed care perspective.药物经济学:管理式医疗视角
Top Hosp Pharm Manage. 1994 Jan;13(4):54-9.
3
Incorporating pharmacoeconomic principles into hospital pharmacy practice.将药物经济学原理纳入医院药学实践。
Top Hosp Pharm Manage. 1994 Jan;13(4):31-7.
4
Evaluating the role of bias in pharmacoeconomic studies.
Manag Care Interface. 2001 Aug;14(8):57-60.
5
Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.经济、临床和人文结果:药物经济学研究的规划模型
Clin Ther. 1993 Nov-Dec;15(6):1121-32; discussion 1120.
6
The use of pharmacoeconomic data in formulary selection.药物经济学数据在药品目录遴选中的应用。
Top Hosp Pharm Manage. 1994 Jan;13(4):47-53.
7
Economic outcomes and contemporary pharmacy practice.经济成果与当代药学实践。
Am Pharm. 1993 Dec;NS33(12 Suppl):S3-6.
8
Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" market.评论:药物经济学与结果研究:拓展医疗保健“结果”市场
Value Health. 2000 May-Jun;3(3):181-5. doi: 10.1046/j.1524-4733.2000.33003.x.
9
Realities of conducting pharmacoeconomic evaluations as part of clinical trials.作为临床试验一部分进行药物经济学评估的实际情况。
Pharm Pract Manag Q. 1995 Jul;15(2):72-81.
10
Use and misuse of pharmacoeconomic terms: a definitions primer.
Top Hosp Pharm Manage. 1994 Jan;13(4):11-22.